FDA Seeks Input to Advance Botanical Drug Development
Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has issued a Request for...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has issued a Request for...
North Chicago, Illinois, USA, September 3, 2026 AbbVie has completed its acquisition of Apogee Therapeutics, strengthening the pharmaceutical company’s...
Alameda, California, USA, September 4, 2026 Acepodia has announced that the U.S. Food and Drug Administration (FDA) has cleared...
Audubon, Pennsylvania, USA, September 3, 2026 Globus Medical has announced that its Excelsius3Dâ„¢ Imaging System has received the CE...
Geneva, Switzerland , Aug 26, 2026 Spineart and eCential Robotics have announced that the U.S. Food and Drug Administration...
PORTLAND, Ore., July 29, 2026 Trace Biosciences, Inc. has secured a strategic investment from Axogen, Inc. to accelerate clinical...
Boston, USA | May 1, 2026 Zeta Surgical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
NEW YORK, NY & CHICAGO, IL, Feb. 16, 2026 — VB Spine LLC announced it has entered into a...
